ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

DCE Concepts Statements

March 11, 1988

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980

Tempero, Johnson To Lead ASCO

March 28, 2003

Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release

April 26, 1985

CMS Withholds Coverage of CT Colonography

May 15, 2009

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012